NDC 68382-668

acyclovir

Acyclovir

acyclovir is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Acyclovir.

Product ID68382-668_beded6e9-8043-4b8f-a048-4ebb0a6be58e
NDC68382-668
Product TypeHuman Prescription Drug
Proprietary Nameacyclovir
Generic NameAcyclovir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2016-05-03
Marketing CategoryANDA / ANDA
Application NumberANDA204313
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NameACYCLOVIR
Active Ingredient Strength200 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68382-668-01

100 CAPSULE in 1 BOTTLE (68382-668-01)
Marketing Start Date2016-05-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-668-05 [68382066805]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03
Inactivation Date2020-01-31

NDC 68382-668-10 [68382066810]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03
Inactivation Date2020-01-31

NDC 68382-668-01 [68382066801]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03
Inactivation Date2020-01-31

NDC 68382-668-16 [68382066816]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03
Inactivation Date2020-01-31

NDC 68382-668-30 [68382066830]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03
Marketing End Date2016-05-12

NDC 68382-668-06 [68382066806]

acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA204313
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-12
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR200 mg/1

OpenFDA Data

SPL SET ID:4c744bf4-7086-40f0-9091-e4096d4e9d41
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197310

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "acyclovir" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    68071-1841AcyclovirAcyclovir
    68071-3155AcyclovirAcyclovir
    68071-3222AcyclovirAcyclovir
    68071-4528AcyclovirAcyclovir
    68071-4559acycloviracyclovir
    68071-4345AcyclovirAcyclovir
    68084-109AcyclovirAcyclovir
    68084-108AcyclovirAcyclovir
    68071-4790AcyclovirAcyclovir
    68071-4799AcyclovirAcyclovir
    68084-107ACYCLOVIRACYCLOVIR
    68382-125acycloviracyclovir
    68382-049acycloviracyclovir
    68382-048acycloviracyclovir
    68382-668acycloviracyclovir
    68382-126acycloviracyclovir
    68382-792acycloviracyclovir
    68382-791acycloviracyclovir
    68382-992acycloviracyclovir
    68462-746acycloviracyclovir
    68788-6360acycloviracyclovir
    68788-0505AcyclovirAcyclovir
    68788-0504AcyclovirAcyclovir
    68788-0715AcyclovirAcyclovir
    68788-8989acycloviracyclovir
    68788-6827ACYCLOVIRACYCLOVIR
    68788-7382acycloviracyclovir
    68788-7378acycloviracyclovir
    68788-9783AcyclovirAcyclovir
    68788-7342AcyclovirAcyclovir
    68788-9690AcyclovirAcyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.